DNA SYNTHESIS AND THE SECRETION OF PROLACTIN AND GROWTH HORMONE BY THE PITUITARY GLAND OF THE MALE RAT: EFFECTS OF DIETHYLSTILBOESTROL AND 2-BROMO-α-ERGOCRYPTINE METHANESULPHONATE

1974 ◽  
Vol 61 (3) ◽  
pp. 411-417 ◽  
Author(s):  
CAROL DAVIES ◽  
JOAN JACOBI ◽  
H. M. LLOYD ◽  
J. D. MEARES

SUMMARY The effects of 2-bromo-α-ergocryptine methanesulphonate on the response of the pituitary gland of the male rat to diethylstilboestrol dipropionate were studied by radioimmunoassay of prolactin and growth hormone and measurements of DNA synthesis. Given before diethylstilboestrol, 2-bromo-α-ergocryptine prevented the oestrogen-induced rise in serum prolactin and partly inhibited pituitary DNA synthesis. Given on days 4–6 of a 6-day period after a single dose of diethylstilboestrol, 2-bromo-α-ergocryptine rapidly increased pituitary prolactin concentration, diminished serum prolactin, reduced pituitary DNA synthesis and did not affect the growth hormone response to oestrogen.

1977 ◽  
Vol 72 (1) ◽  
pp. 35-39 ◽  
Author(s):  
JOAN JACOBI ◽  
H. M. LLOYD ◽  
J. D. MEARES

SUMMARY The times of onset of oestrogen-induced prolactin secretion and DNA synthesis were studied in the pituitary gland of the male rat. At intervals from 3 to 96 h after injection of 10 mg diethylstilboestrol dipropionate, serum and pituitary prolactin concentrations were measured by radioimmunoassay and pituitary DNA synthesis by incorporation of [3H]thymidine in vitro. Serum prolactin was raised significantly from 6 h onwards and DNA synthesis was increased from 30 h onwards. Pituitary prolactin concentration began to increase at 30 h. Significant correlations were obtained between serum prolactin and DNA synthesis from 24 to 72 h but not during the period of prolactin secretion from 6 to 24 h.


1978 ◽  
Vol 77 (1) ◽  
pp. 129-136 ◽  
Author(s):  
H. M. LLOYD ◽  
J. M. JACOBI ◽  
J. D. MEARES

Haloperidol, bromocriptine and diethylstilboestrol dipropionate were given in various régimes to male rats to determine their effects on pituitary DNA synthesis, prolactin secretion and growth hormone secretion. Haloperidol increased serum prolactin but did not stimulate pituitary DNA synthesis or reduce pituitary prolactin concentrations. Haloperidol potentiated the effects of oestrogen on serum prolactin and on pituitary DNA synthesis; pituitary prolactin concentrations were greatly reduced, and growth hormone secretion was slightly inhibited. The inhibitory effects of bromocriptine in oestrogen-stimulated rats were demonstrated by smaller pituitary weights and decreased DNA synthesis; serum prolactin levels were lowered and pituitary prolactin concentrations were increased. Haloperidol, given to rats treated with oestrogen and bromocriptine, reversed the inhibitory effects of bromocriptine on DNA synthesis and serum prolactin; pituitary prolactin concentrations fell to well below normal. The results suggest that the haloperidol potentiation of oestrogeninduced pituitary DNA synthesis may depend upon stimulation of prolactin secretion together with reduction of intracellular prolactin levels.


Sign in / Sign up

Export Citation Format

Share Document